Paul E. Freiman, Director at NovaBay Pharmaceuticals, Inc. (NBY), sold 15,000 shares at $1.83 ($27K) on 2010-08-16, disclosed to the SEC on 2010-08-18.
Open-market sale of $27k NBY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |